Vor Biopharma (VOR) Change in Acquisitions & Divestments (2022 - 2026)

Vor Biopharma (VOR) has reported Change in Acquisitions & Divestments for 5 consecutive years, with $13.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 1331000.0% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $18.3 million (down 65.45% YoY), while the FY2025 annual figure was $5.0 million, down 95.33% from the prior year.
• Change in Acquisitions & Divestments climbed to $13.3 million in Q1 2026 per VOR's latest filing, from $5.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $54.0 million in Q1 2024 and bottomed at -$1000.0 in Q2 2025.
• Historically, Change in Acquisitions & Divestments has averaged $25.6 million across 5 years, with a median of $24.2 million in 2022.
• Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments sank 100.0% — and 2026, when it surged 1331000.0%.
• Vor Biopharma's Change in Acquisitions & Divestments stood at $21.4 million in 2022, then climbed by 25.99% to $27.0 million in 2023, then jumped by 96.3% to $53.0 million in 2024, then slumped by 90.57% to $5.0 million in 2025, then soared by 166.22% to $13.3 million in 2026.
• Business Quant data shows VOR's Change in Acquisitions & Divestments at $13.3 million in Q1 2026, $5.0 million in Q4 2025, and -$1000.0 in Q2 2025.